MarketResearchReports.Biz
presents this most up-to-date research on “Hepatitis D Global
Clinical Trials Review, H2, 2016 ”
GlobalData's
clinical trial report,
Hepatitis D
Global Clinical Trials Review, H2, 2016" provides an overview of
Hepatitis D clinical trials scenario. This report provides top line
data relating to the clinical trials on Hepatitis D. Report includes
an overview of trial numbers and their average enrollment in top
countries conducted across the globe. The report offers coverage of
disease clinical trials by region, country (G7 & E7), phase,
trial status, end points status and sponsor type. Report also
provides prominent drugs for in-progress trials (based on number of
ongoing trials). GlobalData Clinical Trial Reports are generated
using GlobalDatas proprietary database - Pharma eTrack Clinical
trials database. Clinical trials are collated from 80+ different
clinical trial registries, conferences, journals, news etc across the
globe. Clinical trials database undergoes periodic update by dynamic
process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
Download
Sample copy of this Report at
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons
to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Table
of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average
Enrollment by Country 7
Top Countries Contributing to
Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing
to Clinical Trials in Europe 10
Top Countries Contributing to
Clinical Trials in North America 11
Top Countries Contributing to
Clinical Trials in Middle East and Africa 12
Top Countries Contributing to
Clinical Trials in Central and South America 13
Clinical Trials by G7
Countries: Proportion of Hepatitis D to Infectious Disease Clinical
Trials 14
Clinical Trials by Phase in G7
Countries 15
Clinical Trials in G7 Countries
by Trial Status 16
Clinical Trials by E7
Countries: Proportion of Hepatitis D to Infectious Disease Clinical
Trials 17
Clinical Trials by Phase in E7
Countries 18
Clinical Trials in E7 Countries
by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status
22
Clinical Trials by End Point
Status 23
Subjects Recruited Over a
Period of Time 24
Clinical Trials by Sponsor Type
25
Prominent Sponsors 26
Top Companies Participating in
Hepatitis D Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on
Hepatitis D 30
Jul 20, 2016: Eiger
BioPharmaceuticals Announces Completion of Dosing in Phase 2 LOWR HDV
- 3 Study at National Institutes of Health 30
Jun 01, 2016: Maxwell Biotech
Venture Fund's Portfolio Company Hepatera Announces Publication of
Myrcludex B Clinical Results in Journal of Hepatology 30
May 25, 2016: Maxwell Biotech
Venture Fund's Portfolio Company Hepatera Announces Start Of Second
Phase 2 Clinical Trial Of Myrcludex B In Chronic Hepatitis B/D
Infection 30
Clinical Trial Profile
Snapshots 32
Appendix 53
Abbreviations 53
Definitions 53
Research Methodology 54
Secondary Research 54
About GlobalData 55
Contact Us 55
Disclaimer 55
Source 56
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment